Access Vascular this week received FDA clearance for its second-generation HydroPICC peripherally inserted central catheter.
The HydroPICC has demonstrated thrombus accumulation rate 30 times less than traditional peripherally inserted central catheters (PICC), according to the company.
PICCs can help reduce the risk of catheter occlusions have become a popular choice over traditional central venous lines because of ease of use, decreased risk, reduced cost and the ability to be placed by non-physicians.
Get the full story on our sister site, Medical Tubing + Extrusion.